Enovis CORP

Key metrics

Financial performance

Over the last 9 fiscal years Enovis CORP's revenue declined from $3.19B to $2.25B, a compound annual decline rate of 3.8%. Net profit margin compressed from 4.0% to -52.7% over the same period - every figure below comes from the company's audited annual filings.

Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.

Key statistics

Latest filings

Browse the full filing history (1,645 filings)

Recent press releases

• Enovis Announces First Quarter 2026 Results2026-05-07

  First-quarter sales growth of 5% on a reported basis

• Enovis to Host First Quarter 2026 Results Conference Call on May 7th2026-04-10

  Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (800) 715-9871 (U.S. callers) and (646) 307-1963 (International callers) and use Conference ID: 3314793. A link to a replay of the call will also be available on the Enovis website later that day.

• Enovis Announces Fourth Quarter and Full Year 2025 Results2026-02-26

  Continued commercial momentum with full year 2025 sales growth of 7% on a reported basis and 6% organically

• Enovis™ (NYSE: ENOV) is a global medical technology innovator dedicated to improving lives by developing clinically differentiated solutions that enhance patient outcomes and restore motion for life. We partner with the brightest minds in health to advance care that is smarter, personalized, and more effective, while improving operational efficiency for surgeons and clinicians around the world. Enovis solutions impact the well-being of millions of patients wherever they are on their pathway to health. Discover more about Enovis at www.enovis.com2026-02-03

  Enovis™ (NYSE: ENOV) is a global medical technology innovator dedicated to improving lives by developing clinically differentiated solutions that enhance patient outcomes and restore motion for life. We partner with the brightest minds in health to advance care that is smarter, personalized, and more effective, while improving operational efficiency for surgeons and clinicians around the world. Enovis solutions impact the well-being of millions of patients wherever they are on their pathway to health. Discover more about Enovis at www.enovis.com

• Enovis to Host Fourth Quarter and Full Year 2025 Results Conference Call on February 26th2026-01-23

  Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (833) 685-0901 (U.S. callers) and (412) 317-5715 (International callers) and ask to join the Enovis call. A link to a replay of the call will also be available on the Enovis website later that day.

Similar companies

The largest companies sharing Enovis CORP's SEC industry classification (orthopedic, prosthetic & surgical appliances & supplies).